Leonardo Roever: Brain Age as a Biomarker of Neuroplasticity and Motor Recovery After Stroke
Leonardo Roever, CEO of Brazilian Evidence-Based Health Network, shared on LinkedIn about a recent article by Gilsoon Park et al, published in The Lancet Digital Health:
”Associations between contralateral neuroplasticity and motor impairment through deep learning-derived regional brain age in MRI in chronic stroke (ENIGMA): an observational, retrospective, multicenter study
Stroke leads to complex brain changes, both structural and functional, that specifically affect motor outcomes.
Predicted brain age difference (PBAD) has emerged as a sensitive biomarker of both sensorimotor and cognitive function after stroke.
A previous study found a higher global brain PBAD associated with worse motor function after stroke.
However, the association between local stroke lesion burden, regional brain age, and motor impairment is unclear.
This study aimed to investigate the associations between focal lesion damage, regional brain PBAD in both hemispheres, and motor outcomes in chronic stroke, and to identify key predictors of motor impairment.
The findings of this study reveal that larger stroke lesions are associated with accelerated aging in the ipsilateral hemisphere and, paradoxically, with decelerated brain aging in the contralateral hemisphere, suggesting compensatory neural mechanisms.
Regional brain age assessment can serve as a biomarker for neuroplasticity and guide targeted interventions to improve motor recovery after stroke.”
Title: Associations between contralesional neuroplasticity and motor impairment through deep learning-derived MRI regional brain age in chronic stroke (ENIGMA): a multicohort, retrospective, observational study
Authors: Gilsoon Park, Mahir H Khan, Justin W Andrushko, Nerisa Banaj, Michael R Borich, Lara A Boyd, Amy Brodtmann, Truman R Brown, Cathrin M Buetefisch, Adriana B Conforto, Steven C Cramer, Michael Dimyan, Martin Domin, Miranda R Donnelly, Natalia Egorova-Brumley, Elsa R Ermer, Wuwei Feng, Fatemeh Geranmayeh, Colleen A Hanlon, Brenton Hordacre, Neda Jahanshad, Steven A Kautz, Mohamed Salah Khlif, Jingchun Liu, Martin Lotze, Bradley J MacIntosh, Feroze B Mohamed, Jan E Nordvik, Fabrizio Piras, Kate P Revill, Andrew D Robertson, Christian Schranz, Nicolas Schweighofer, Na Jin Seo, Surjo R Soekadar, Shraddha Srivastava, Bethany P Tavenner, Gregory T Thielman, Sophia I Thomopoulos, Daniela Vecchio, Emilio Werden, Lars T Westlye, Carolee J Winstein, George F Wittenberg, Jennifer K Ferris, Chunshui Yu, Paul M Thompson, Sook-Lei Liew, Hosung Kim
Read the Full Article on The Lancet Digital Health
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE
-
Apr 14, 2026, 16:54Chokri Ben Lamine: Extracorporeal Photopheresis for aGVHD cGVHD Post-SCT – 50 Pearls
-
Apr 14, 2026, 16:49Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS